NASDAQ:HYPR Hyperfine (HYPR) Stock Price, News & Analysis → The AI stock to buy right now (From StockEarnings) (Ad) Free hypr Stock Alerts $0.79 -0.01 (-1.25%) (As of 05/2/2024 ET) Add Compare Share Share Today's Range$0.77▼$0.8350-Day Range$0.80▼$1.2552-Week Range$0.77▼$3.28Volume70,553 shsAverage Volume69,019 shsMarket Capitalization$57.05 millionP/E RatioN/ADividend YieldN/APrice Target$2.12 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Hyperfine alerts: Email Address Hyperfine MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside167.0% Upside$2.12 Price TargetShort InterestBearish2.64% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.53) to ($0.50) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.90 out of 5 starsMedical Sector597th out of 907 stocksElectromedical Equipment Industry12th out of 21 stocks 3.2 Analyst's Opinion Consensus RatingHyperfine has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageHyperfine has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted2.64% of the float of Hyperfine has been sold short.Short Interest Ratio / Days to CoverHyperfine has a short interest ratio ("days to cover") of 16.6, which indicates bearish sentiment.Change versus previous monthShort interest in Hyperfine has recently decreased by 3.10%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldHyperfine does not currently pay a dividend.Dividend GrowthHyperfine does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HYPR. Previous Next 1.9 News and Social Media Coverage News SentimentHyperfine has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Hyperfine this week, compared to 1 article on an average week.MarketBeat Follows2 people have added Hyperfine to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Hyperfine insiders have not sold or bought any company stock.Percentage Held by Insiders26.50% of the stock of Hyperfine is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 15.03% of the stock of Hyperfine is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Hyperfine are expected to grow in the coming year, from ($0.53) to ($0.50) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hyperfine is -1.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Hyperfine is -1.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHyperfine has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad StockEarningsThe AI stock to buy right nowThere are about 350,000 large corporations worldwide. Can you see the potential for this AI company to grow like crazy?Click Here to Get the AI Stock Name About Hyperfine Stock (NASDAQ:HYPR)Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.Read More HYPR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HYPR Stock News HeadlinesApril 30, 2024 | americanbankingnews.comCritical Comparison: Hyperfine (NASDAQ:HYPR) and NeurAxis (NASDAQ:NRXS)April 25, 2024 | americanbankingnews.comHyperfine (NASDAQ:HYPR) Trading Down 1.1%May 3, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.April 23, 2024 | businesswire.comHyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical ConditionsApril 17, 2024 | msn.comHyperfine (HYPR) Price Target Decreased by 6.02% to 1.33April 17, 2024 | businesswire.comLeading Institutions Enroll First Alzheimer's Patients Receiving Amyloid-Targeting Therapy in CARE PMR StudyMarch 23, 2024 | markets.businessinsider.comChallenges Ahead: Revising Hyperfine’s Outlook Amid Lower-than-Expected Financial PerformanceMarch 22, 2024 | msn.comHyperfine, Inc. (NASDAQ:HYPR) Q4 2023 Earnings Call TranscriptMay 3, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.March 21, 2024 | investorplace.comHYPR Stock Earnings: Hyperfine Beats EPS, Misses Revenue for Q4 2023March 21, 2024 | benzinga.comRecap: Hyperfine Q4 EarningsMarch 21, 2024 | globenewswire.comHyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 12, 2024 | finance.yahoo.comHyperfine, Inc. Collaborates with King’s College London to Demonstrate the Swoop® System and UNITY Project to The Princess RoyalMarch 12, 2024 | businesswire.comHyperfine, Inc. Collaborates with King's College London to Demonstrate the Swoop® System and UNITY Project to The Princess RoyalMarch 7, 2024 | businesswire.comHyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024February 28, 2024 | finance.yahoo.comHyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare ConferenceFebruary 24, 2024 | morningstar.comHyperfine Inc Class A HYPRFebruary 21, 2024 | businesswire.comHyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional AthletesFebruary 11, 2024 | investing.comHYPR/USD - Hypr Network US DollarJanuary 9, 2024 | finance.yahoo.comHyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of UseDecember 1, 2023 | benzinga.comHyperfine Stock (NASDAQ:HYPR) Earnings Dates and Earning CallsDecember 1, 2023 | markets.businessinsider.comMaintaining Hold on Hyperfine: Weighing Swoop MRI’s Market Entry Challenges Against Future Growth ProspectsNovember 30, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Hyperfine (HYPR) and Johnson & Johnson (JNJ)November 30, 2023 | benzinga.comHyperfine Stock (NASDAQ:HYPR) Dividends: History, Yield and DatesNovember 30, 2023 | msn.comJefferies starts Hyperfine at hold, says company still in early commercial stageNovember 30, 2023 | msn.comJefferies Initiates Coverage of Hyperfine Inc - (HYPR) with Hold RecommendationNovember 20, 2023 | finance.yahoo.comHyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023See More Headlines Receive HYPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hyperfine and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/21/2024Today5/02/2024Next Earnings (Confirmed)5/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:HYPR CUSIPN/A CIK1833769 Webhyperfine.io Phone866-796-6767FaxN/AEmployees131Year FoundedN/APrice Target and Rating Average Stock Price Target$2.12 High Stock Price Target$3.50 Low Stock Price Target$1.25 Potential Upside/Downside+167.0%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.62) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-44,240,000.00 Net Margins-401.00% Pretax Margin-401.00% Return on Equity-44.89% Return on Assets-40.96% Debt Debt-to-Equity RatioN/A Current Ratio10.14 Quick Ratio9.39 Sales & Book Value Annual Sales$11.03 million Price / Sales5.17 Cash FlowN/A Price / Cash FlowN/A Book Value$1.17 per share Price / Book0.68Miscellaneous Outstanding Shares71,950,000Free Float52,883,000Market Cap$57.05 million OptionableOptionable Beta0.82 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. R. Scott Huennekens CPA (Age 60)M.B.A., Executive Chairman Comp: $1.29MMs. Maria Sainz (Age 58)CEO, President & Director Comp: $340.24kDr. Jonathan M. Rothberg Ph.D. (Age 60)Founder & Vice Chairman Comp: $51.37kMr. Brett Hale (Age 50)Chief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Corporate Secretary Dr. Thomas Teisseyre Ph.D.Chief Operating OfficerMr. Chip Truwit FACRM.D., Vice President of Scientific AffairsMore ExecutivesKey CompetitorsMovanoNASDAQ:MOVEPixie Dust TechnologiesNASDAQ:PXDTelectroCoreNASDAQ:ECORPrecision OpticsNASDAQ:POCIVivani MedicalNASDAQ:VANIView All CompetitorsInsiders & InstitutionsJourney Strategic Wealth LLCBought 74,929 shares on 2/9/2024Ownership: 0.105%Thomas TeisseyreSold 2,655 sharesTotal: $3,345.30 ($1.26/share)Khan SiddiquiSold 1,735 sharesTotal: $2,168.75 ($1.25/share)View All Insider TransactionsView All Institutional Transactions HYPR Stock Analysis - Frequently Asked Questions Should I buy or sell Hyperfine stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hyperfine in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" HYPR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HYPR, but not buy additional shares or sell existing shares. View HYPR analyst ratings or view top-rated stocks. What is Hyperfine's stock price target for 2024? 3 equities research analysts have issued 12-month price targets for Hyperfine's shares. Their HYPR share price targets range from $1.25 to $3.50. On average, they expect the company's share price to reach $2.12 in the next year. This suggests a possible upside of 167.0% from the stock's current price. View analysts price targets for HYPR or view top-rated stocks among Wall Street analysts. How have HYPR shares performed in 2024? Hyperfine's stock was trading at $1.12 at the beginning of the year. Since then, HYPR stock has decreased by 29.2% and is now trading at $0.7929. View the best growth stocks for 2024 here. When is Hyperfine's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our HYPR earnings forecast. How can I listen to Hyperfine's earnings call? Hyperfine will be holding an earnings conference call on Monday, May 13th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link. How were Hyperfine's earnings last quarter? Hyperfine, Inc. (NASDAQ:HYPR) released its quarterly earnings results on Thursday, March, 21st. The company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.17) by $0.02. The company had revenue of $2.69 million for the quarter, compared to analyst estimates of $3.66 million. Hyperfine had a negative net margin of 401.00% and a negative trailing twelve-month return on equity of 44.89%. What guidance has Hyperfine issued on next quarter's earnings? Hyperfine issued an update on its FY 2024 earnings guidance on Thursday, March, 21st. The company provided EPS guidance of for the period. The company issued revenue guidance of $12.0 million-$15.0 million, compared to the consensus revenue estimate of $18.4 million. How do I buy shares of Hyperfine? Shares of HYPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HYPR) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersThe AI stock to buy right nowStockEarningsCould Your Accounts Be Frozen?Allegiance GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetry$5,000 Gold?Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBill Gates is all about this tiny $2 stockTimothy SykesNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hyperfine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
